Research on The Role of Complement Regulatory Membrane Factors in The Initiation and Progression of Glomerular Injury

补体调节膜因子在肾小球损伤发生和进展中的作用研究

基本信息

  • 批准号:
    06671136
  • 负责人:
  • 金额:
    $ 1.54万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

This project was performed to elusidate the in vivo role of complement regulatory membrane factors (CRMFs) in the pathegenesis of glomerular injury. CRMFs work at two levels, i. e., the level of C3 amplification and the level of formation of membrane attack complex (MAC). The following new findings were obtained from this research project. (1) Both in human and rats, CRMFs were significantly expressed in the normal kidney including glomeruli, and in other organs. (2) Systemic suppression of the function of these factors in vivo by neutralizing monoclonal antibodies result in the endotoxin shock-like symptoms in rats. It was demonstrated for the first time by this finding that CRMFs play crucial roles for the protection of host organs from the spontaneously occurring complement attack. (3) Using an isolated kidney perfusion system developed in our laboratory, selective suppression of CRMFs in the kidney was achieved in rats. When complement-dependent glomerular injury was induced in the … More se CRMF-suppressed rats, glomerular injury was significantly enhanced with increased deposition of complement activation products. From these findings, it was testified in vivo for the first time that CRMFs in the glomeruli play protective roles in the pathogenesis of this kind of glomerular injury.The following preliminary findings concerning the role of CRMFs in the pathogenesis of tubulointerstitial injury were also obtained by the present research project. (1) Functional suppression of tubulointerstitial CRMF resulted in the development of tubulointerstitial lesion without any complement-activating stimuli. Thus, CRMFs are important for maintaining the normal integrity of the kidney. (2) Functional suppression of CRMFs in the peritubular capillaries resulted in the increased permeability for plasma proteins, and in the tubulointerstitial injury. It is concluded that promotion of the research in this field must greatly contribute to the understanding of the mechanisms of progressive renal injury. Less
本研究旨在探讨补体调节膜因子(CRMFs)在肾小球损伤发病中的作用。CRMF在两个层面上工作,i。例如,C3扩增水平和膜攻击复合物(MAC)形成水平。从这个研究项目中获得了以下新发现。(1)在人和大鼠中,CRMF在正常肾脏(包括肾小球)和其他器官中均显著表达。(2)通过中和性单克隆抗体在体内系统抑制这些因子的功能导致大鼠内毒素休克样症状。这一发现首次证明了CRMF在保护宿主器官免受自发发生的补体攻击方面起着至关重要的作用。(3)使用我们实验室开发的离体肾脏灌注系统,在大鼠中实现了对肾脏中CRMF的选择性抑制。当补体依赖性肾小球损伤诱导在 ...更多信息 在CRMF抑制的大鼠中,肾小球损伤随着补体激活产物沉积的增加而显著增强。本研究首次在体内证实了肾小球CRMFs在肾小管间质损伤的发病机制中起保护作用,并对CRMFs在肾小管间质损伤的发病机制中的作用进行了初步研究。(1)肾小管间质CRMF的功能抑制导致肾小管间质病变的发展,没有任何补体激活刺激。因此,CRMF对于维持肾脏的正常完整性是重要的。(2)肾小管周围毛细血管中CRMF的功能抑制导致血浆蛋白的渗透性增加和肾小管间质损伤。结论:促进这一领域的研究,将大大有助于了解进行性肾损伤的机制。少

项目成果

期刊论文数量(58)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yuzawa Y: "Interaction of antibody with Forssman antigen in Guinea pigs." American Journal of Pathology. 146. 1260-1272 (1995)
Yuzawa Y:“抗体与豚鼠福斯曼抗原的相互作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hatanaka,Y: "Role of a rat membrane inhibitor of complement in antibasement membrane antibody-induced renal injury." Kidney International. 48. 1728-1737 (1995)
Hatanaka,Y:“大鼠膜补体抑制剂在抗基底膜抗体诱导的肾损伤中的作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsuo S,Ichida S,Takizawa H,Okada N,Baranyi L,Iguchi A,Morgan BP and Okada H: "In vivo effects of monoclonal antibodies which functionally inhibit complement regulatory proteins in rats." J Exp Med. 180. 1619-1627 (1994)
Matsuo S、Ichida S、Takizawa H、Okada N、Baranyi L、Iguchi A、Morgan BP 和 Okada H:“功能性抑制大鼠补体调节蛋白的单克隆抗体的体内作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ichida,S: "Localization of complement regulatory proteins in the normal human kidney." kidney International. 46. 89-96 (1994)
Ichida,S:“补体调节蛋白在正常人肾脏中的定位。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsuo,S.: "The role of CD59 in the complement-mediated glomerular injury in rats." Kidney International. 46. 191-200 (1994)
Matsuo,S.:“CD59 在大鼠补体介导的肾小球损伤中的作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MATSUO Seiichi其他文献

MATSUO Seiichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MATSUO Seiichi', 18)}}的其他基金

Development of novel therapy for kidney injury by leukocyte targeting antibody-fused Bionanocapsules
开发白细胞靶向抗体融合生物纳米胶囊治疗肾损伤的新疗法
  • 批准号:
    25670408
  • 财政年份:
    2013
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Elucidation of molecular mechanisms involved in the immunomodulatory function of newly developed adipose tissue derived mesenchymal stem cells
阐明新开发的脂肪组织来源的间充质干细胞的免疫调节功能的分子机制
  • 批准号:
    23659443
  • 财政年份:
    2011
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
International comparison of genomic variations for prognostic factors in chronic kidney disease
慢性肾脏病预后因素基因组变异的国际比较
  • 批准号:
    23406027
  • 财政年份:
    2011
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Epidemiological analysis on chronic kidney disease in Asian population after standardization of creatinine measurement
肌酐测量标准化后亚洲人群慢性肾脏病的流行病学分析
  • 批准号:
    20406022
  • 财政年份:
    2008
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Clinical implication of urinary midkine as a sensitive biomarker of acute kidney injury
尿中期因子作为急性肾损伤敏感生物标志物的临床意义
  • 批准号:
    18390247
  • 财政年份:
    2006
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Asian Collaborative Study for Creation of GFR Estimation Equation (ACOS-CG-FREE)
创建 GFR 估计方程的亚洲合作研究 (ACOS-CG-FREE)
  • 批准号:
    18406032
  • 财政年份:
    2006
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Basic research for the development of new therapeutic measures against progressive tubuloinetsrtitial injury.
开发针对进行性肾小管损伤的新治疗措施的基础研究。
  • 批准号:
    15390269
  • 财政年份:
    2003
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Research on The Role of Proximal Tubular Cells in The Development of Tubulointerstitinal Injury.
近端肾小管细胞在肾小管间质损伤发展中作用的研究。
  • 批准号:
    13671110
  • 财政年份:
    2001
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a novel therapeutic approach to the renal injury by the control of anaphylatoxins.
通过控制过敏毒素开发一种新的肾损伤治疗方法。
  • 批准号:
    13557085
  • 财政年份:
    2001
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The Role of Anaphylatoxins, C3a, C5a, in Renal Injury.
过敏毒素、C3a、C5a 在肾损伤中的作用。
  • 批准号:
    11671033
  • 财政年份:
    1999
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

白茅根抗肾小球肾炎物质基础及免疫机制研究
  • 批准号:
    30860363
  • 批准年份:
    2008
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Glycan biomarker panels in liquid biopsies for predicting treatment response in lupus nephritis
液体活检中的聚糖生物标志物组用于预测狼疮性肾炎的治疗反应
  • 批准号:
    10601270
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
Genetics and Immune Predictors for Recurrent Glomerular Diseases in the Kidney Allograft
同种异体移植肾中复发性肾小球疾病的遗传学和免疫预测因子
  • 批准号:
    10637158
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
The role of human SLE causal variant NCF1.pR90H in promoting kidney damage
人类SLE致病变异N​​CF1.pR90H在促进肾脏损伤中的作用
  • 批准号:
    10740630
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
The Serine Protease HTRA1 Antigen: A Gateway to Elucidating Membranous Nephropathy Pathogenesis and the Targeting of Antigen Epitopes
丝氨酸蛋白酶 HTRA1 抗原:阐明膜性肾病发病机制和抗原表位靶向的途径
  • 批准号:
    10740614
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
High-throughput identification and transcriptional analysis of autoreactive T cells in individuals with membranous nephropathy.
膜性肾病患者自身反应性 T 细胞的高通量鉴定和转录分析。
  • 批准号:
    10725558
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
Identifying autoimmune associated genes in patrolling monocytes that promote lupus nephritis
识别巡逻单核细胞中促进狼疮肾炎的自身免疫相关基因
  • 批准号:
    10726991
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
Rationally Designed, Target-specific Imaging Probes for Nephro-urology Diagnoses
用于肾泌尿科诊断的合理设计、针对特定目标的成像探头
  • 批准号:
    10659440
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
CureGN
治愈GN
  • 批准号:
    10877511
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
Preclinical and Clinical Models of Drug Induced Kidney Injury
药物性肾损伤的临床前和临床模型
  • 批准号:
    10745197
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
PLA2R1 Loss-of-Function: A Monogenic Cause of Sarcoidosis in African-Americans in the ACCESS Cohort
PLA2R1 功能丧失:ACCESS 队列中非裔美国人结节病的单基因原因
  • 批准号:
    10651396
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了